Peripheral-blood dendritic cells in men with coronary heart disease

Hongyu Shi1, Junbo Ge, Weiyi Fang

  • 1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.

Insights

Coronary artery disease (CAD) patients show higher levels of dendritic cells (DCs), particularly myeloid DCs (mDCs), compared to controls. This increase in mDCs may contribute to the heightened T-helper type 1 (Th1) immune response observed in CAD.

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Cell Biology

Background:

  • An imbalance in T-helper type 1 (Th1)/T-helper type 2 (Th2) immune responses, favoring Th1, is implicated in coronary artery disease (CAD).
  • Dendritic cells (DCs), including myeloid DCs (mDCs) and plasmacytoid DCs (pDCs), are key regulators of T-helper cell differentiation and immune responses.

Purpose of the Study:

  • To investigate the levels of total peripheral-blood dendritic cells (DCs) and their subsets (mDCs and pDCs) in patients with coronary artery disease (CAD).
  • To determine if DC subset distribution differs between CAD patients and healthy controls, potentially explaining the skewed Th1/Th2 balance in CAD.

Main Methods:

  • Peripheral blood samples were collected from 32 men undergoing coronary angiography, divided into a CAD group (n=21) and a control group (n=11).
  • A 3-color flow cytometry technique was used to quantify total DCs, mDCs (Lin1(-)HLA-DR(+)CD11c(+)), and pDCs (Lin1(-)HLA-DR(+)CD123(+)).

Main Results:

  • The absolute number of total peripheral-blood DCs was significantly higher in the CAD group compared to the control group (p=0.04).
  • Both the percentage and absolute number of the mDC subset were significantly increased in CAD patients (p<0.05).
  • The pDC fraction remained similar between groups, but the mDC/pDC ratio was significantly elevated in the CAD group (p=0.01).

Conclusions:

  • Patients with coronary artery disease exhibit significantly higher numbers of total peripheral-blood dendritic cells.
  • The observed increase in the myeloid DC subset in CAD patients may be a contributing factor to the enhanced Th1 immune response characteristic of the disease.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...